Cancer Center

Primitive neuroectodermal tumors (PNETs) arise from undifferentiated brain cells and are the most frequent malignant brain tumors in children. There are different forms of PNETs and, while scientists have made progress in characterizing the genetic abnormalities associated with some PNET subtypes, the highly aggressive cerebral tumors known as CNS-PNETs have been difficult to characterize as they represent a relatively uncommon group of tumors with ill-defined diagnostic features.

“Lack of insight into the molecular pathogenesis of CNS-PNET is a major obstacle towards development of disease-specific models and treatments for these frequently fatal malignancies,” explains senior study author, Dr. Annie Huang from the Hospital for Sick Children in Ontario, Canada. To comprehensively define relevant genetic alterations associated with CNS-PNET, Dr. Huang established international collaborations with colleagues from pediatric oncology centers in Asia, Europe and the United States to complete a sophisticated high resolution genomic screen of a large collection of primary tumors.

» Read more: New Hope for Diagnosis and Treatment of Intractable Pediatric Brain Tumors

Related posts

• Avoiding Cancer One Day At A Time: Practical Advice For Preventing Cancer
• Using gold nanoparticles to hit cancer where it hurts
• Scientists make anti-cancer compounds
• Long term, tamoxifen stops more cancer than Evista
• Winning the war on cancer? Disease rates in U.S. drop below where they were in 1970s